ipriflavone has been researched along with Hypogonadism in 2 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Hypogonadism: Condition resulting from deficient gonadal functions, such as GAMETOGENESIS and the production of GONADAL STEROID HORMONES. It is characterized by delay in GROWTH, germ cell maturation, and development of secondary sex characteristics. Hypogonadism can be due to a deficiency of GONADOTROPINS (hypogonadotropic hypogonadism) or due to primary gonadal failure (hypergonadotropic hypogonadism).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gambacciani, M | 1 |
| Cappagli, B | 1 |
| Piaggesi, L | 1 |
| Ciaponi, M | 1 |
| Genazzani, AR | 1 |
| Ohishi, T | 1 |
| Koide, Y | 1 |
| Takahashi, M | 1 |
| Oikawa, M | 1 |
| Kushida, K | 1 |
1 trial available for ipriflavone and Hypogonadism
| Article | Year |
|---|---|
Ipriflavone prevents the loss of bone mass in pharmacological menopause induced by GnRH-agonists.
Topics: Absorptiometry, Photon; Analysis of Variance; Antineoplastic Agents, Hormonal; Bone Density; Bone Re | 1997 |
1 other study available for ipriflavone and Hypogonadism
| Article | Year |
|---|---|
A case of femoral neck fracture in a patient with severe testosterone deficiency.
Topics: Aged; Bone Density; Calcitonin; Femoral Neck Fractures; Humans; Hydroxycholecalciferols; Hypogonadis | 1999 |